Breaking News

Journal of Parkinson’s Disease welcomes new c

impression: Lorraine V. Kalia, MD, PhD, FRCPC
see more 

Credit rating: Lorraine V. Kalia, MD, PhD, FRCPC

Amsterdam, May perhaps 20, 2022 – The Journal of Parkinson’s Condition (JPD), printed by IOS Press, is happy to announce the appointment of new co-Editor-in-Main, Lorraine V. Kalia, MD, PhD, FRCPC. Dr. Kalia joins co-Editor-in-Chief Bas Bloem, MD, PhD, FRCPE, and an eminent intercontinental editorial board, who are dedicated to the continuing achievement of the world’s major journal in Parkinson’s analysis.

A globally acknowledged authority on Parkinson’s illness, Lorraine V. Kalia, MD, PhD, FRCPC, is an Associate Professor and Clinician Scientist in the Division of Neurology at the College of Toronto and a Senior Scientist at the Krembil Study Institute of the University Well being Network. She retains appointments with the College of Toronto’s Tanz Centre for Investigation in Neurodegenerative Illnesses and Department of Laboratory Drugs and Pathobiology. She is also a Staff Neurologist in the Morton and Gloria Shulman Motion Problems Clinic and the Edmond J. Safra Application in Parkinson’s Disorder at the Toronto Western Healthcare facility, College Well being Network.

Dr. Kalia serves as Co-Chair of the Scientific Troubles Committee and a Steering Committee Member of the Primary Science Particular Fascination Group of the Intercontinental Parkinson and Movement Ailment Society. Her clinical do the job and research application focus on Parkinson’s ailment and linked motion diseases. With an eye generally on the clinic, she heads a study staff targeted on elucidating the vital molecular mechanisms dependable for neurodegeneration in Parkinson’s ailment and pinpointing therapeutic agents that can goal these molecular mediators of neurodegeneration.

Dr. Kalia’s appointment follows the departure of just one of JPD’s founding editors, Patrik Brundin, MD, PhD, who has moved out of academia and is now Therapeutic Space Chief for Motion Problems at Roche Pharmaceutical Analysis and Early Progress. Dr. Brundin served as co-Editor-in-Chief for 12 yrs, from its days as a fledging journal to its recent placement as a primary publisher of groundbreaking Parkinson’s investigation. He seems to be forward to seeing the journal’s continued advancement and results.

Dr. Kalia commented, “I am thrilled to be stepping into the job of co-Editor-in-Main, despite the fact that I recognize that Patrik’s sneakers are quite massive types to fill. Bas and Patrik have completed remarkable operate for the journal, increasing its get to and impression above the past few decades. I glimpse ahead to operating with Bas and the crew to retain this positive trajectory by more acquiring the journal as a one of a kind open up forum for excellent investigate into Parkinson’s that also features the voice of those people affected by the condition.”

“I could not be much more thrilled that Lorraine Kalia has consented to sign up for JPD as the new co-Editor-in-Chief,” included Dr. Bloem, Radboud College Nijmegen Health-related Centre. “Dr. Kalia has an excellent track document in the discipline of Parkinson research, and she is a wonderful colleague to work with. She and I are now working on plans to just take our journal to the subsequent level, so be sure to remain tuned for far more facts before long!”

 


Disclaimer: AAAS and EurekAlert! are not liable for the accuracy of information releases posted to EurekAlert! by contributing institutions or for the use of any data by the EurekAlert technique.